The intragraft expression of CXCL10 (p = 0.0068) and TLR4 (p = 0.0056) was also significantly increased in patients who experienced HCC recurrence, as opposed to those who did not, which is consistent with the findings of myeloid-derived suppressor cell (MDSC) analysis. The gene discussed is CXCL10; the disease is hepatocellular carcinoma.